The next generation in POC anticoagulation testing from Roche Diagnostics

CLIA-Waived

The CoaguChek® XS System A smart way to test

The NEW CoaguChek XS SystemThe new CoaguChek XS System uses exclusive smart technology to help ensure accurate results, and offers the fl exibility and control that healthcare professionals need to confi dently manage a wide range of anticoagulated patients.

Accurate and fl exible technology• Accurate, precise results in one minute• The only system to perform onboard quality control and determine patient results in a

single test chamber1, 2

• Neutralizes therapeutic levels of heparin and LMWH1

• INR corrected for hematocrit within specifi ed range – manage a broad array of patientswith one device1

Easy and convenient to use• Small sample size (10µl) for easy dosing• Strip allows dosing from either top or side for simple blood application• 18-month strip shelf life – no refrigeration needed• Outside meter blood application – minimizes potential for cross-contamination1

• Small, battery-powered, handheld meter for portability and effi ciency

Effi cient and cost-effective• New onboard controls – no external QC necessary• Auto-on with strip insertion and auto-off capabilities• Testing, treatment and potential revenue capture in one appointment3

• Fingerstick test that patients prefer4

The leader in point-of-care anticoagulation monitoringSince 1994, Roche Diagnostics has helped healthcare professionals provide quality care to their patients with a PT/INR meter they trust. Find out why 4 out of 5 point-of-care PT/INR tests are performed with a CoaguChek system.5 Contact your Roche representative to schedule an in-offi ce demonstration.

1 CoaguChek XS System package insert. Indianapolis, IN. Roche Diagnostics Corporation, 2006.2 INRatio® System package insert. Milpitas, CA. HemoSense Inc., 2003. ProTime® System package insert. Edison, NJ. ITC, 2006.3 Campbell, P., Radensky, P., Denham, C. Economic analysis of systematic anticoagulation management vs. routine medical care

for patients on oral warfarin therapy. Disease Management and Clinical Outcomes, December 2000.4 Fintel D. and Hoffman C. The physician’s guide to preventing strokes and lowering health risks in patients with atrial fi brillation.

Northwest University Medical School, 1997.5 Third quarter 2006 total market share of projected distributor unit sales of the Point of Care Testing Coagulation Reagents and

Kits product class by HPIS Market Intelligence, a division of GHX Global Healthcare Exchange. Total Market includes all market sectors as defi ned by HPIS: Physician, Long Term Care, Treatment Centers, Clinical Laboratory, Hospital, Home Healthcare and Other/Unspecifi ed. Data on fi le.

POC anticoagulation testing with the CoaguChek XS System — a smart way to test

Roche Diagnostics Corporation9115 Hague RoadIndianapolis, IN 46250

COAGUCHEK is a trademark of Roche. All other trademarks are the property of their respective owners. © 2007 Roche Diagnostics. All rights reserved. 573-33892-1206

www.coaguchek.comwww.roche-diagnostics.us

800-434-2909 www.amms.net